Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Corus Entertainment Inc. (CJR.B-T) announced an agreement to amend and extend the terms of its existing credit facility with its bank group, led by RBC Capital Markets and TD Securities. “Pursuant to the amendment, the term facility under the credit facility was adjusted from $2.1-billion to $1.8-billion, reflecting principal repayments made since the facility was last amended,” the company stated. “The credit facility was originally established in connection with the closing of Corus’ acquisition of Shaw Media Inc. to partially fund the purchase price for the acquisition and to replace the company’s existing credit facilities, with the terms subsequently amended and extended in November 2017 and on May 31, 2019.”

**

Story continues below advertisement

Aimia Inc. (AIM-T) announced that it and Air Canada have finalized all post-closing adjustments from the previously-announced sale of Aeroplan Inc. “A final payment to Aimia by Air Canada of approximately $19-million will result in the transaction having a total purchase price of approximately $516-million,” the company stated. “The post-closing adjustments were primarily related to favourable working capital relative to the target working capital set out in the share purchase agreement.”

The company also said it will file a notice of objection contest the re-assessments from Canada Revenue Agency.

**

Ballard Power Systems (BLDP-Q; BDLP-T) announced it will provide fuel cell modules for buses in Europe as a member of the new H2Bus Consortium.

"The H2Bus consortium is a very exciting development in the deployment of zero-emission fuel cell electric buses across Europe," stated Ballard CEO Randy MacEwen. "Consortium members intend to provide the most affordable zero-emission bus and hydrogen fuelling solution in order to meet the increasing demand for clean public transportation in Europe's largest cities."

**

FSD Pharma Inc. (HUGE-C) named Raza Bokhari as permanent CEO. Dr. Bokhari has served as interim CEO of the company since February.

Story continues below advertisement

**

MORE TO COME

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter